**Question:** Amplification of N-Myc is associated with which tumor?

**Core Concept:** N-Myc is a proto-oncogene that, when amplified, can lead to uncontrolled cell growth and tumor formation. Proto-oncogenes are normal cellular genes that, when mutated, can contribute to the development of cancer.

**Why the Correct Answer is Right:** N-Myc amplification is a common event in neuroblastoma, a malignant tumor that develops from neural crest cells in the embryonic neural tube, particularly in infants and young children. When N-Myc is amplified, it promotes rapid cell division and inhibits apoptosis, contributing to the uncontrolled growth of neuroblast cells and tumor formation.

**Why Each Wrong Option is Incorrect:**

A. N-Myc amplification is not associated with acute lymphoblastic leukemia (ALL) or lymphomas.
B. Although N-Myc can contribute to the development of medulloblastoma (a type of brain tumor), amplification is more commonly associated with neuroblastoma.
C. N-Myc amplification does not typically occur in osteosarcoma (bone cancer) or chondrosarcoma (cartilage cancer).
D. As stated earlier, N-Myc amplification is more commonly associated with neuroblastoma than with glioblastoma multiforme (brain cancer).

**Why Option D is Right:**

N-Myc amplification is a defining feature of high-risk neuroblastoma, particularly in infants and young children. The amplification of N-Myc contributes to the uncontrolled growth of neural crest cells, leading to the development of neuroblastoma.

**Clinical Pearl:** Understanding the role of proto-oncogenes like N-Myc in cancer development is crucial for diagnosing and treating various types of tumors effectively. Knowledge of these mechanisms can aid in developing targeted therapies and personalized medicine approaches for cancer patients.